Liver Perfusion Imaging in Patients with Primary and Metastatic Liver Malignancy. Prospective Comparison between 99mTc-MAA SPECT and Dynamic CT Perfusion

Academic Radiology

Volumn 19, Issue 5, 2012, Pages 613-621

  Reiner, Caecilia S ^a   Goetti, Robert ^a   Burger, Irene A ^a   Fischer, Michael A ^a   Frauenfelder, Thomas ^a   Knuth, Alexander ^a   Pfammatter, Thomas ^a   Schaefer, Niklaus ^a   Alkadhi, Hatem ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

99mTc MAA SPECT; Computed tomography; Liver; Malignant liver tumor; Perfusion

Indexed keywords

MACROSALB TC 99M; VASCULOTROPIN ANTIBODY;

ADULT; AGED; ANUS CARCINOMA; ANUS SQUAMOUS CELL CARCINOMA; ARTERIAL LIVER PERFUSION; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONVENTIONAL ANGIOGRAPHY; DIAGNOSTIC IMAGING; DRUG UPTAKE; EPITHELIOID HEMANGIOENDOTHELIOMA; EXTRAHEPATIC CHOLANGIOCARCINOMA; FEMALE; HUMAN; IMAGE ANALYSIS; INTRAHEPATIC CHOLANGIOCARCINOMA; KIDNEY CARCINOMA; LIVER CANCER; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER PERFUSION; LUNG NON SMALL CELL CANCER; MALE; MELANOMA; METASTASIS; MULTIMODALITY CANCER THERAPY; PANCREAS ADENOCARCINOMA; PORTAL VEIN EMBOLIZATION; PORTAL VEIN LIGATION; PORTAL VENOUS PERFUSION; PRIMARY TUMOR; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SARCOMA; SELECTIVE INTERNAL RADIOTHERAPY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STOMACH ADENOCARCINOMA; TOTAL LIVER PERFUSION;

ADULT; AGED; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PERFUSION IMAGING; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84858997818     PISSN: 10766332     EISSN: 18784046     Source Type: Journal    
DOI: 10.1016/j.acra.2011.12.015     Document Type: Article

References (40)

1. Jakobs T.F., Hoffmann R.T., Poepperl G., et al. Mid-term results in otherwise treatment refractory primary or secondary liver confined tumours treated with selective internal radiation therapy (SIRT) using (90)Yttrium resin-microspheres. Eur Radiol 2007, 17:1320-1330.
2. Dancey J.E., Shepherd F.A., Paul K., et al. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres. J Nucl Med 2000, 41:1673-1681.
3. Dudeck O., Zeile M., Wybranski C., et al. Early prediction of anticancer effects with diffusion-weighted MR imaging in patients with colorectal liver metastases following selective internal radiotherapy. Eur Radiol 2010, 20:2699-2706.
4. Campbell A.M., Bailey I.H., Burton M.A. Analysis of the distribution of intra-arterial microspheres in human liver following hepatic yttrium-90 microsphere therapy. Phys Med Biol 2000, 45:1023-1033.
5. Leen E., Goldberg J.A., Anderson J.R., et al. Hepatic perfusion changes in patients with liver metastases: comparison with those patients with cirrhosis. Gut 1993, 34:554-557.
6. Bledin A.G., Kim E.E., Chuang V.P., et al. Changes of arterial blood flow patterns during infusion chemotherapy, as monitored by intra-arterially injected technetium 99m macroaggregated albumin. Br J Radiol 1984, 57:197-203.
7. Bilbao J.I., de Martino A., de Luis E., et al. Biocompatibility, inflammatory response, and recannalization characteristics of nonradioactive resin microspheres: histological findings. Cardiovasc Intervent Radiol 2009, 32:727-736.
8. Flamen P., Vanderlinden B., Delatte P., et al. Multimodality imaging can predict the metabolic response of unresectable colorectal liver metastases to radioembolization therapy with Yttrium-90 labeled resin microspheres. Phys Med Biol 2008, 53:6591-6603.
9. Ho S., Lau W.Y., Leung T.W., et al. Tumour-to-normal uptake ratio of 90Y microspheres in hepatic cancer assessed with 99Tcm macroaggregated albumin. Br J Radiol 1997, 70:823-828.
10. Knesaurek K., Machac J., Muzinic M., et al. Quantitative comparison of yttrium-90 (90Y)-microspheres and technetium-99m (99mTc)-macroaggregated albumin SPECT images for planning 90Y therapy of liver cancer. Technol Cancer Res Treat 2010, 9:253-262.
11. Miles K.A., Hayball M.P., Dixon A.K. Functional images of hepatic perfusion obtained with dynamic CT. Radiology 1993, 188:405-411.
12. Haberland U., Klotz E., Abolmaali N. Performance assessment of dynamic spiral scan modes with variable pitch for quantitative perfusion computed tomography. Invest Radiol 2010, 45:378-386.
13. Goetti R., Leschka S., Desbiolles L., et al. Quantitative computed tomography liver perfusion imaging using dynamic spiral scanning with variable pitch: feasibility and initial results in patients with cancer metastases. Invest Radiol 2010, 45:419-426.
14. Meijerink M.R., van Waesberghe J.H., van der Weide L., et al. Early detection of local RFA site recurrence using total liver volume perfusion CT initial experience. Acad Radiol 2009, 16:1215-1222.
15. Ippolito D., Sironi S., Pozzi M., et al. Hepatocellular carcinoma in cirrhotic liver disease: functional computed tomography with perfusion imaging in the assessment of tumor vascularization. Acad Radiol 2008, 15:919-927.
16. Fournier L.S., Oudard S., Thiam R., et al. Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT. Radiology 2010, 256:511-518.
17. Chen Y., Zhang J., Dai J., et al. Angiogenesis of renal cell carcinoma: perfusion CT findings. Abdom Imaging 2010, 35:622-628.
18. Goh V., Halligan S., Wellsted D.M., et al. Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study. Eur Radiol 2009, 19:79-89.
19. Chen G., Ma D.Q., He W., et al. Computed tomography perfusion in evaluating the therapeutic effect of transarterial chemoembolization for hepatocellular carcinoma. World J Gastroenterol 2008, 14:5738-5743.
20. Saddi KA, Chefd'hotel C, Cheriet F. Large deformation registration of contrast-enhanced images with volume-preserving constraint. In: Pluim JPW, Reinhard JM, eds. Medical Imaging 2007: Image Processing. Bellingham, WA: Proceedings of The International Society for Optical Engineering (SPIE), 2007.
21. Blomley M.J., Coulden R., Dawson P., et al. Liver perfusion studied with ultrafast CT. J Comput Assist Tomogr 1995, 19:424-433.
22. Tsushima Y., Funabasama S., Aoki J., et al. Quantitative perfusion map of malignant liver tumors, created from dynamic computed tomography data. Acad Radiol 2004, 11:215-223.
23. Hamami M.E., Poeppel T.D., Muller S., et al. SPECT/CT with 99mTc-MAA in radioembolization with 90Y microspheres in patients with hepatocellular cancer. J Nucl Med 2009, 50:688-692.
24. Ahmadzadehfar H., Sabet A., Biermann K., et al. The significance of 99mTc-MAA SPECT/CT liver perfusion imaging in treatment planning for 90Y-microsphere selective internal radiation treatment. J Nucl Med 2010, 51:1206-1212.
25. Gyves J.W., Ziessman H.A., Ensminger W.D., et al. Definition of hepatic tumor microcirculation by single photon emission computerized tomography (SPECT). J Nucl Med 1984, 25:972-977.
26. Goldberg J.A., Bradnam M.S., Kerr D.J., et al. Single photon emission computed tomographic studies (SPECT) of hepatic arterial perfusion scintigraphy (HAPS) in patients with colorectal liver metastases: improved tumour targetting by microspheres with angiotensin II. Nucl Med Commun 1987, 8:1025-1032.
27. Ho S., Lau W.Y., Leung T.W., et al. Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours. Eur J Nucl Med 1996, 23:947-952.
28. Bilbao J.I., Garrastachu P., Herraiz M.J., et al. Safety and efficacy assessment of flow redistribution by occlusion of intrahepatic vessels prior to radioembolization in the treatment of liver tumors. Cardiovasc Intervent Radiol 2010, 33:523-531.
29. Veit-Haibach P., Treyer V., Strobel K., et al. Feasibility of integrated CT-liver perfusion in routine FDG-PET/CT. Abdom Imaging 2010, 35:528-536.
30. Cuenod C., Leconte I., Siauve N., et al. Early changes in liver perfusion caused by occult metastases in rats: detection with quantitative CT. Radiology 2001, 218:556-561.
31. Breedis C., Young G. The blood supply of neoplasms in the liver. Am J Pathol 1954, 30:969-977.
32. Kandel S., Kloeters C., Meyer H., et al. Whole-organ perfusion of the pancreas using dynamic volume CT in patients with primary pancreas carcinoma: acquisition technique, post-processing and initial results. Eur Radiol 2009, 19:2641-2646.
33. Youn S.W., Kim J.H., Weon Y.C., et al. Perfusion CT of the brain using 40-mm-wide detector and toggling table technique for initial imaging of acute stroke. AJR Am J Roentgenol 2008, 191:W120-W126.
34. Helck A., Sommer W.H., Klotz E., et al. Determination of glomerular filtration rate using dynamic CT-angiography: simultaneous acquisition of morphological and functional information. Invest Radiol 2010, 45:387-392.
35. Goh V., Liaw J., Bartram C.I., et al. Effect of temporal interval between scan acquisitions on quantitative vascular parameters in colorectal cancer: implications for helical volumetric perfusion CT techniques. AJR Am J Roentgenol 2008, 191:W288-W292.
36. Goh V., Dattani M., Farwell J., et al. Radiation dose from volumetric helical perfusion CT of the thorax, abdomen or pelvis. Eur Radiol 2011, 21:974-981.
37. Kierkels R.G., Backes W.H., Janssen M.H., et al. Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer. Int J Radiat Oncol Biol Phys 2010, 77:400-408.
38. Goetti R., Reiner C.S., Knuth A., et al. Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound. Invest Radiol 2012, 47:18-24.
39. Kapanen M., Halavaara J., Hakkinen A.M. Comparison of liver perfusion parameters studied with conventional extravascular and experimental intravascular CT contrast agents. Acad Radiol 2007, 14:951-958.
40. Leung W.T., Lau W.Y., Ho S.K., et al. Measuring lung shunting in hepatocellular carcinoma with intrahepatic-arterial technetium-99m macroaggregated albumin. J Nucl Med 1994, 35:70-73.